Clinical trial
Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients…
NCT00260026 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00260026 |
|---|---|
| Title | Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer |
| Official title | Safety and Pharmacokinetic Study of Jin Fu Kang In Combination With Docetaxel for Patients With Previously Treated Non-Small Cell Lung Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Jin Fu Kang |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Dec 1, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: